Weight loss drugs linked to hair loss in men

A recent study suggests a potential link between the use of GLP-1 medications, which are used to treat diabetes and obesity, and an increased risk of patterned hair loss in men with a genetic predisposition to this condition. The findings indicated that men carrying genetic factors associated with androgenetic alopecia—a common form of hair loss—may face an approximately 7% higher risk of hair loss when using drugs such as Ozempic, Wegovy, and ZepBound. The research focused on the GLP1R gene, which is related to the activity of GLP-1 receptors, and showed that increased activity of this gene raises the likelihood of hair loss, even after accounting for other factors like hypertension and insulin resistance. It is thought that the relationship is not solely due to rapid weight loss often seen with these medications, but may also involve a genetic response to heightened GLP-1 pathway activity. The researchers plan further studies to identify individuals most at risk and hope that these findings will aid in developing preemptive methods to assess the risk of hair loss before starting treatment.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل